Department of Orthopedics Surgery, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu Province, China.
Postgraduate in Orthopedics Surgery, Nanjing Medical University, Nanjing, Jiangsu Province, China.
Adv Rheumatol. 2024 Jan 29;64(1):12. doi: 10.1186/s42358-023-00337-9.
In a recent genome-wide association study, novel genetic variations of WNT9A were reported to be involved in the etiopathogenesis of thumb osteoarthritis (TOA) in Caucasians. Our purposes were to replicate the association of WNT9A with the development of TOA in the Chinese population and to further unveil the functional role of the risk variants.
SNP rs11588850 of WNT9A were genotyped in 953 TOA patients and 1124 healthy controls. The differences of genotype and allele distributions between the patients and healthy controls were evaluated using the Chi-square test. Luciferase Reporter Assay was performed to investigate the influence of variant on the gene expression.
There was significantly lower frequency of genotype AA in TOA patients than in the controls 74.9% vs. 81.9%, p < 0.001). The frequency of allele A was remarkably lower in the patients than in the controls (86.3% vs. 90.5%, p < 0.001), with an odds ratio of 0.66 (95% CI = 0.54-0.80). Luciferase Reporter Assay showed that the construct containing mutant allele G of rs11588850 displayed 29.1% higher enhancer activity than the wild allele A construct (p < 0.05).
Allele G of rs11588850 was associated with the increased risk of TOA possibly via up-regulation of WNT9A expression. Further functional analysis into the regulatory role of rs11588850 in WNT9A expression can shed new light on the genetic architecture of TOA.
在最近的全基因组关联研究中,报道了 WNT9A 的新遗传变异与高加索人群的拇指骨关节炎(TOA)发病机制有关。我们的目的是复制 WNT9A 与中国人群 TOA 发病的关联,并进一步揭示风险变异的功能作用。
WNT9A 的 SNP rs11588850 在 953 例 TOA 患者和 1124 例健康对照中进行了基因分型。使用卡方检验评估患者和健康对照之间基因型和等位基因分布的差异。荧光素酶报告基因检测用于研究变异对基因表达的影响。
TOA 患者的基因型 AA 频率明显低于对照组(74.9% vs. 81.9%,p<0.001)。患者的等位基因 A 频率明显低于对照组(86.3% vs. 90.5%,p<0.001),优势比为 0.66(95%CI=0.54-0.80)。荧光素酶报告基因检测显示,含有 rs11588850 突变等位基因 G 的构建体比野生型等位基因 A 构建体的增强子活性高 29.1%(p<0.05)。
rs11588850 的等位基因 G 可能通过上调 WNT9A 表达与 TOA 的发病风险增加相关。进一步研究 rs11588850 在 WNT9A 表达中的调节作用的功能分析,可以为 TOA 的遗传结构提供新的见解。